WhiteSwell is a science-driven company dedicated to improving treatment of acute decompensated heart failure (ADHF), a primary cause of repeat hospitalization and emergency room visits.  The company is pioneering a minimally invasive catheter-based approach designed to more efficiently remove excess interstitial fluid in patients with ADHF by enhancing the natural fluid removal process of the lymphatic system. For more information visit www.whiteswell.com.

Health Care

Life Sciences

Medical Devices

WhiteSwell

Eamon Brady

Michael Jonas

Alva Bradley

George Bakris

Suzanne Hansel

Joann Lindenfeld

Ronan Keating

Martin Keegan

Jill Amstutz

Ann Marie Cannon

Andrew Levin

Andrew Farquharson

Seán Mac Réamoinn

The Leadership Team at WhiteSwell is responsible for guiding the strategic direction, operational excellence, and financial health of the company. This team works collectively to advance the development and commercialization of innovative treatments for acute decompensated heart failure (ADHF). Their tasks include overseeing technical operations, ensuring regulatory compliance, optimizing research and development efforts, and driving market positioning to transform patient care.

Leadership Team

Medical Professionals

Research and Development

Leadership Team

About

Team members

Other teams at WhiteSwell

Medical Professionals

Research and Development